Constellation Health
Weight Loss

Sema (GLP-1)

Lyophilized *MUST BE RECONSTITUTED* Introducing Sema (GLP-1), a powerful peptide designed for research. As a synthetic glucagon-like peptide

Lyophilized *MUST BE RECONSTITUTED* Introducing Sema (GLP-1), a powerful peptide designed for research. As a synthetic glucagon-like peptide-1 (GLP-1) analog, it enhances insulin production, lowers glucose levels, preserves pancreatic beta cells in research settings.

Sema (GLP-1) 5mg

Sema (GLP-1) - 5mg

Lyophilized *MUST BE RECONSTITUTED* Introducing Sema (GLP-1), a powerful peptide designed for research. As a synthetic glucagon-like peptide

$39/mo

Vial Size

People also buy

GLOW GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg)

GLOW GHK-CU (50mg) / BPC-157 (10mg) / TB500 (10mg)

$180
HCG

HCG

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that has been widely studied for its role in the reproductive and endocrine systems, including the regulation of sex hormone production. For research use only.

$125

SemaMelt

Semaglutide/Pyridoxine 10mg sublingual tablet

$312

SemaTirzeMelt

Semaglutide + Tirzepatide sublingual tablet

$720
TirzMelt

TirzMelt

1 pill a day

$588
AOD-9604 (Reconstituted) - 10mg

AOD-9604 (Reconstituted) - 10mg

Reconstituted at 10mg / 4mL

$150
Tirz (GLP-2)

Tirz (GLP-2)

Lyophilized *MUST BE RECONSTITUTED* Tirz (GLP-2), a synthetic derivative of gastric inhibitory polypeptide (GIP), exhibits simultaneous gluc

$100
Reta (GLP-3)

Reta (GLP-3)

Lyophilized *MUST BE RECONSTITUTED* Meet Reta (GLP-3) , a GGG tri-agonist that uniquely targets GLP-1 and GIP receptors while also activatin

$125

References

  1. Sema (GLP-1) - Peptide Center guide
  2. Tirzepatide as Compared with Semaglutide for the Treatment of ObesityThe New England journal of medicine, 2025
  3. Safety of SemaglutideFrontiers in endocrinology, 2021
  4. Semaglutide for the treatment of obesityTrends in cardiovascular medicine, 2023
  5. Once-Weekly Semaglutide in Persons with Obesity and Knee OsteoarthritisThe New England journal of medicine, 2024
  6. Once-Weekly Semaglutide in Adolescents with ObesityThe New England journal of medicine, 2022
  7. Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesThe New England journal of medicine, 2023

Ready to start with Sema (GLP-1)?

Take our eligibility quiz to see if this treatment is right for you.

Start Intake